InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Lammers Paul. Director active across 1 company, notably Salarius Pharmaceuticals, Inc.. Aggregated, 1 disclosures have been recorded. History available since 3 January 2023. The latest transaction was filed on 3 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration